PolyPeptide Group AG (0AAJ.L)

CHF 19.7

(4.76%)

Total Assets Summary of PolyPeptide Group AG

PolyPeptide Group AG's latest annual total assets in 2023 was 689.08 Million EUR , up 19.68% from previous year.
PolyPeptide Group AG's latest quarterly total assets in 2023 FY was 689.08 Million EUR , up 19.68% from previous quarter.
PolyPeptide Group AG reported annual total assets of 575.78 Million EUR in 2022, down -3.24% from previous year.
PolyPeptide Group AG reported annual total assets of 595.03 Million EUR in 2021, up 58.27% from previous year.
PolyPeptide Group AG reported quarterly total assets of 689.08 Million EUR for 2023 FY, up 19.68% from previous quarter.
PolyPeptide Group AG reported quarterly total assets of 689.08 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Assets Chart of PolyPeptide Group AG (2023 - 2018)

Historical Annual Total Assets of PolyPeptide Group AG (2023 - 2018)

Year	Total Assets	Total Assets Growth
2023	689.08 Million EUR	19.68%
2022	575.78 Million EUR	-3.24%
2021	595.03 Million EUR	58.27%
2020	375.97 Million EUR	23.21%
2019	305.14 Million EUR	7.51%
2018	283.82 Million EUR	0.0%

Year	Total Assets	Total Assets Growth
2023 Q2	589.12 Million EUR	0.0%
2023 FY	689.08 Million EUR	19.68%
2023 Q4	689.08 Million EUR	0.0%
2022 Q4	575.78 Million EUR	0.0%
2022 Q2	579.25 Million EUR	0.0%
2022 FY	575.78 Million EUR	-3.24%
2021 Q4	595.03 Million EUR	0.0%
2021 Q2	571.95 Million EUR	0.0%
2021 FY	595.03 Million EUR	58.27%
2020 FY	375.97 Million EUR	23.21%
2020 Q4	375.97 Million EUR	0.0%
2019 Q4	76.28 Million EUR	0.0%
2019 Q3	76.28 Million EUR	0.0%
2019 Q2	76.28 Million EUR	0.0%
2019 Q1	76.28 Million EUR	7.51%
2019 FY	305.14 Million EUR	7.51%
2018 Q2	70.95 Million EUR	0.0%
2018 Q4	70.95 Million EUR	0.0%
2018 Q3	70.95 Million EUR	0.0%
2018 FY	283.82 Million EUR	0.0%
2018 Q1	70.95 Million EUR	0.0%

Peer Total Assets Comparison of PolyPeptide Group AG

Name	Total Assets	Total Assets Difference
Kuros Biosciences AG	75.9 Million CHF	-807.818%